key: cord-0860573-68r16gvl
authors: Yu, Xinliang
title: Prediction of inhibitory constants of compounds against SARS-CoV 3CLpro enzyme with 2D-QSAR model
date: 2021-05-21
journal: nan
DOI: 10.1016/j.jscs.2021.101262
sha: b858d9f28227bf46cf7026104b75a79c8a0f2c74
doc_id: 860573
cord_uid: 68r16gvl

Developing broad-spectrum anti-coronavirus drugs is greatly important, since the novel SARS-CoV-2 has rapidly become a threat to the public health and economy worldwide. SARS-CoV 3-chymotrypsin-like protease (3CLpro), as highly conserved in betacoronavirus, is a viable target for anti-SARS drugs. A quantitative structure–activity relationship (QSAR) for inhibitory constants (pKi) of 89 compounds against SARS-CoV 3CLpro enzyme was developed by using support vector machine (SVM) and genetic algorithm. The optimal SVM model (C =90.2339 and γ = 1.19826×10-5) based on six molecular descriptors has determination coefficients of 0.839 for the training set (65 compounds) and 0.747 for test set (24 compounds), and rms errors of 0.435 and 0.525, respectively. These results are accurate and acceptable compared with that in other models reported, although our SVM model deals with more samples in the dada set. The SVM model could be beneficial for search of novel 3CLpro enzyme inhibitors against SARS-CoV.

, caused by the SARS-CoV2 virus, has been found all over the world since its first outbreak in Wuhan City, China, in December 2019 [1, 2] . COVID-19 is a potentially fatal disease and becomes a global public health concern [3, 4] . 1,700 people. Their fatality rates were about 10% and 36%, respectively [5, 6] . Although SARS-CoV disappeared mysteriously, the MERS-CoV has not been controlled so far.

SARS-CoV2 is the 3rd human coronavirus disease discovered in the 21st century. At present, there are no specific and effective drugs for COVID-19. SARS-CoV 3-chymotrypsin-like protease (3CLpro) is one of the major proteases produced by the 2019-nCoV, which plays a pivotal role in the replication of the virus [7, 8] .

Most of the functional proteins of coronavirus are encoded by ORF1ab gene. The coding

RNAs are translated into a proteome (7096aa), and then cut into multiple active proteins (e.g. viral replication protein RdRp) by 3CLpro. In addition, 3CLpro may cleave the intracellular protein NEMO and inhibit the activation of interferon signaling pathway. Therefore, SARS-CoV 3CLpro plays an important role in the virus life cycle and has become a viable target for anti-SARS drug development. There is more than 95% sequence similarity in RdRp and 3CLpro between SARS-CoV-2 and SARS-CoV [3] [4] [5] [6] [7] [8] . Therefore, 3CLpro inhibitors developed on SARS-CoV could be effective against SARS-CoV-2 [7, 8] .

Quantitative structure-activity relationship (QSAR) models can be used for drug screening and mechanistic understanding of drug action. This technique has many advantages, such as lower-cost and higher speed, even can be used to evaluate drug candidates that have not been synthesized [9, 10] . But only a few researchers have carried out QSAR studies for inhibitor activities against SARS-CoV.

Inhibitory constant (Ki) is the concentration of the inhibitor that is required in order to decrease the maximal rate of the reaction by half. Masand et al. introduced a QSAR model for activities (Ki) of SARS-CoV 3CLpro inhibitors [7] . A six-descriptor model was based on a training set (50 compounds) and evaluated with a test set (12 compounds) . Although the data sets are relatively small, the coefficients of determination R 2 are 0.824 for the training set and 0.758 for the test set, which are accurate and satisfactory. Kumar and Roy built up an eight-descriptor model for inhibitory activities (IC 50 ) of 69 molecules against SARS-CoV 3CLpro enzyme [8] . The data set was divided into a training set (56 molecules) and a test set (13 molecules ) . Their coefficients of determination R 2 are 0.764 and 0.711, respectively.

The two QSAR models referred to were developed with multiple linear regression (MLR) analysis, which is suitable for linear relationships between dependent variables and independent variables. Generally, nonlinear regression techniques can improve the prediction performance of QSAR models. The aim of this study is to develop a six-descriptor QSAR for inhibitory constants (Ki) of 89 molecules against SARS-CoV 3CLpro enzyme, by applying support vector machine (SVM) technique. It is hoped that our SVM model will be beneficial for search of novel 3CLpro enzyme inhibitors against SARS-CoV.

Table S1 in Supplemental Information shows the SMILES notations and inhibitory constants (Ki) of 89 molecules against SARS-CoV 3CLpro, which were taken from the binding database 11 and references [12] [13] [14] . The experimental Ki values varied from 3 to 56,000 nM, and their pKi (= -logKi) values were in the range of 8.523-4.252 by converting to negative logarithm of Ki. A larger pKi value means a higher activity for the inhibitor. Inhibition constants, Ki, were obtained through measuring the apparent kinetic parameters at a constant substrate concentration (10 µM) and different inhibitor concentrations (0-200 µM) at 25 ºC [12] . These experimental data were randomly split into a training set (n = 65 inhibitors) and a test set (n = 24 inhibitors). QSAR models were developed with the training set and evaluated with test set.

Besides three-dimensional (3D) QSAR methods based on ligand-receptor interactions, the two-dimensional (2D) QSAR models derived only from the ligand molecules can be used for describing the activity of biologically active compounds. The structural and physicochemical features of active compounds become the critical factors determining inhibitory constant (Ki) when the inhibitors have the same biological target (e.g. SARS-CoV 3CLpro enzyme). In this study, the structures of inhibitors were used to derive molecular descriptors for 2D-QSAR models of inhibitory constants (Ki). According to the SMILES notations in Table S1 , molecular structures were drawn using ChemBioDraw Ultra 12.0 in ChemBioOffice 2010.

Subsequently, 3D-structures were generated using ChemBio3D Ultra 12.0 and optimized with 6 semi-empirical AM1 method in Gaussian 09. Finally, the optimized molecules were used to calculate molecular descriptors with Dragon 6.0 [15] . Totally, 648 descriptors were obtained when those molecular descriptors with high co-linearity (|R|>0.90) or being a constant were removed.

For the nonlinear support vector regression machine, the low-dimensional data need be mapped to the high-dimensional space, from which the linearly separable hyperplane would be found. Finally, the hyperplane in the high-dimensional space should be mapped back to the low-dimensional space, so as to realize SVM regression or classification. However, mapping low-dimensional data to high-dimensional space and then performing regression analysis involve a great quantity of computations. Especially for high-dimensional data, the problem of over-fitting can occur. Kernel function is introduced to solve this problem. Replacing the linear terms in linear equations with kernel function can make the original linear algorithm nonlinear, that is to say, it can do nonlinear regression. Thus, the introduction of kernel function can achieve the purpose of increasing dimension and effectively control over fitting.

Radial basis function was used in this work. The SVM parameters C (the regulation constant) and γ (the width of kernel function) need to be optimized with genetic algorithm, since too large or too small C (and γ) values may lead to over-fitting or under-fitting and reduce model's predictive power. 7 

Stepwise multiple linear regression (MLR) analysis was performed using IBM SPSS Statistical 19 for 89 pKi (in Table S1 Table 1 . We found that the determination coefficients of MLR models were improved when Table S1 in Supplemental Information) were used to develop QSAR in this work. The MLR model has determination coefficients R 2 of 0.598 for the training set and 0.659 for test set. [15] , which are calculated with: atomic polarizability (p), atomic ionization potential (i), or intrinsic state (s)) used for weighting molecular graphs, nAT is the total number of molecule atoms, δ ij denotes the Kronecker delta and Δ denotes the sum of the Kronecker deltas [15] . MATSkw are correlated with molecular size, geometry and symmetry [16, 17] .

The descriptor nArNR2 denotes the number of tertiary amines (aromatic), i.e. ArNYY in Table 2 , the six new descriptors have low significance values (< 0.05), which mean that they are important independent variables to correlate with the inhibitory constants (pKi). The variance inflation factors (VIF) are less than 10, implying no serious multicollinearity problem. By the t-test values in Table 2 , the |t-test| values increase in the sequence: Leave-one-out (LOO) cross-validation, together with genetic algorithm [19, 20] , was selected to train the QSAR models for pKi of 65 compounds in the training set. The ranges of C from 0 to 600 and γ from 0 and 1 were searched. In the end, the relatively optimal parameters C (=90.2339) and γ (= 1.19826×10 -5 ) were obtained. The optimal SVM (C = 90.2339 and γ = 1.19826×10 -5 ) model was evaluated with 24 compounds in the test set. The pKi values calculated from the SVM model were listed in Table S1 in Supplemental Information and illustrated in Fig. 1 . [21] . Therefore, the pKi SVM model built in this work is successful. Here k and k' are slopes of regression lines, q ext 2 is external correlation coefficient, R 2 is square of correlation coefficient, R 0 2 and R' 0 2 determination coefficient. These definitions of above parameters can be found in references [21] [22] [23] Figure 2 shows the Williams plot of the standardized residuals () against the leverages (h) of both the training and test sets of the optimal SVM model. The predictions may be considered reliable if the samples fall into the domain of Williams plot [19] . In Fig. 2 

No conflict of interest to declare

Corona Virus: A Review of COVID-19 History and Origin

COVID-19: Pathogenesis, cytokine storm and therapeutic potential of interferons

Perspectives on monoclonal antibody therapy as potential therapeutic intervention for Coronavirus disease-19 (COVID-19), Asian Pac

Research and Development on Therapeutic Agents and Vaccines for COVID-19 and Related Human Coronavirus Diseases

Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods

Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2

Structure Features of Peptide-Type SARS-CoV Main Protease Inhibitors: Quantitative Structure Activity Relationship Study

Development of a simple, interpretable and easily transferable QSAR model for quick screening antiviral databases in search of novel 3Clike protease (3CLpro) enzyme inhibitors against SARS-CoV diseases

Optimization of antiproliferative activity of substituted phenyl 4-(2-oxoimidazolidin-1-yl) benzenesulfonates: QSAR and CoMFA analyses

Tautomerism and multiple modelling enhance the efficacy of QSAR: antimalarial activity of phosphoramidate and phosphorothioamidate analogues of amiprophos methyl

BindingDB: A public database for medicinal chemistry, computational chemistry and systems pharmacology

Design and synthesis of new tripeptide-type SARS-CoV 3CL protease inhibitors containing an electrophilic arylketone moiety

Development of potent dipeptide-type SARS-CoV 3CL protease inhibitors with novel P3 17 scaffolds: Design, synthesis, biological evaluation, and docking studies

Design, synthesis, and biological evaluation of novel dipeptide-type SARS-CoV 3CL protease inhibitors: Structure-activity relationship study

DRAGON (Software for Molecular Descriptor Calculation) Version 6.0

Prediction of the maximum nonseizure load of lubricant additives

Prediction of the onset temperature of decomposition of lubricant additives

LIBSVM: A library for support vector machines

Quantitative structure-toxicity relationships of organic chemicals against Pseudokirchneriella subcapitata

Ecotoxicological QSAR modelling of organic chemicals against Pseudokirchneriella subcapitata using consensus predictions approach

DFT-based quantum theory QSPR studies of molar heat capacity and molar polarization of vinyl polymers

Multiple quantitative structure-activity relationships (QSARs) analysis for orally active trypanocidal N-myristoyltransferase inhibitors

QSAR analysis for 6-arylpyrazine-2-carboxamides as Trypanosoma brucei inhibitors

How precise are our quantitative structure-activity relationship derived predictions for new query chemicals